Clinical trial

REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD)

NCT07412782

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DIAGNOSTIC_TEST · Unmapped registry intervention REMS Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD)

Design: INTERVENTIONAL · Status: RECRUITING · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-12-04

PhaseNA

Conditions

Osteogenesis Imperfectaverified · MONDO: osteogenesis imperfecta

Osteoporosisverified · MONDO: osteoporosis

Hypogonadismsunresolved

Neoplasiaverified · MONDO: neoplasm

Obesity & Overweightunresolved

Malnutrition (Calorie)unresolved

Hypercortisolismunresolved

Growth Hormone Deficiency (GHD)unresolved

Osteopeniaunresolved

Interventions

REMSDIAGNOSTIC_TEST

Sponsors & collaborators

Meyer Children's Hospital IRCCSlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07412782 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.